Literature DB >> 18475730

Plasma macrophage colony-stimulating factor levels during cardiopulmonary bypass with extracorporeal circulation.

Y Denizot1, P Fixe, E Cornu, N Nathan.   

Abstract

Leukocytosis and thrombocytopenia occur during cardiopulmonary bypass (CPB) with extracorporeal circulation (ECC). Elevated circulating concentrations of macrophage colony-stimulating factor (M-CSF) are reported during thrombocytopenia and leukopenia of different origins. We have assessed M-CSF concentrations in 40 patients undergoing CPB with ECC. Plasma M-CSF concentrations were stable during ECC and increased at the 6th (7.3 +/- 0.7 IU/mug protein) and 24th (8.6 +/- 0.8 IU/mug protein) postoperative hour compared with pre-ECC values (4.9 +/- 0.5 IU/mug protein). A deep thrombocytopenia was found during ECC and until the 24th postoperative hour. A drop of leukocyte counts was found during ECC followed by an increase after ECC weaning. While no correlation was found between M-CSF concentrations and the leukocyte counts, M-CSF values were positively correlated with platelet counts only before and during ECC. Thus, M-CSF is not implicated in the thrombocytopenia and the leukopenia generated during CPB with ECC. However the elevated levels of M-CSFa few hours after the end of ECC might play a role in the inflammatory process often observed after CPB.

Entities:  

Year:  1996        PMID: 18475730      PMCID: PMC2365806          DOI: 10.1155/S0962935196000518

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  17 in total

Review 1.  Inflammatory response to cardiopulmonary bypass.

Authors:  J Butler; G M Rocker; S Westaby
Journal:  Ann Thorac Surg       Date:  1993-02       Impact factor: 4.330

2.  High titre anticytokine antibodies obtained by intralymphnode immunization with low amounts of antigen.

Authors:  L Coupey; L Berrada; H Gascan; A Godard; V Praloran
Journal:  Cytokine       Date:  1993-11       Impact factor: 3.861

3.  Serum macrophage colony-stimulating factor (M-CSF) levels correlate with clinical response to interferon-alpha in patients with early-stage B-CLL.

Authors:  A P Jewell; K L Yong; C P Worman; C P Tsakona; F J Giles; A H Goldstone
Journal:  Br J Haematol       Date:  1994-02       Impact factor: 6.998

4.  Prostaglandin E2, prostacyclin, and thromboxane changes during nonpulsatile cardiopulmonary bypass in humans.

Authors:  M E Faymonville; G Deby-Dupont; R Larbuisson; C Deby; L Bodson; R Limet; M Lamy
Journal:  J Thorac Cardiovasc Surg       Date:  1986-06       Impact factor: 5.209

Review 5.  The biology and action of colony stimulating factor-1.

Authors:  E R Stanley; K L Berg; D B Einstein; P S Lee; Y G Yeung
Journal:  Stem Cells       Date:  1994       Impact factor: 6.277

6.  Elevation of serum M-CSF concentrations during pregnancy and ovarian hyperstimulation.

Authors:  V Praloran; L Coupey; M Donnard; L Berrada; M F Naud
Journal:  Br J Haematol       Date:  1994-03       Impact factor: 6.998

7.  Human macrophage colony-stimulating factor levels are elevated in pregnancy and in immune thrombocytopenia.

Authors:  K Yong; N Salooja; R E Donahue; U Hegde; D C Linch
Journal:  Blood       Date:  1992-12-01       Impact factor: 22.113

8.  Increased prostacyclin and thromboxane production in man during cardiopulmonary bypass.

Authors:  O Ylikorkala; E Saarela; L Viinikka
Journal:  J Thorac Cardiovasc Surg       Date:  1981-08       Impact factor: 5.209

9.  PAF and haematopoiesis. X. Macrophage colony-stimulating factor and granulocyte macrophage colony-stimulating factor enhance platelet-activating factor acetylhydrolase production by human blood-derived macrophages.

Authors:  F Dupuis; Y Denizot; P Fixe; C Dulery; V Praloran
Journal:  Biochim Biophys Acta       Date:  1996-03-27

10.  Cytokine expression from bone marrow derived macrophages.

Authors:  D S Temeles; H E McGrath; E L Kittler; R K Shadduck; V K Kister; R B Crittenden; B L Turner; P J Quesenberry
Journal:  Exp Hematol       Date:  1993-02       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.